Suchergebnisse - "Carta, Anna R"

PubPharm (83)

1

Region-specific changes in gene expression are associated with cognitive deficits in the alpha-synuclein-induced model of Parkinson's disease : A transcriptomic profiling study

enthalten in: Experimental neurology | 2024

von Manchinu, M. | Pala, M. | Palmas, M. | +11

2

Genetic and Molecular Regulations of Neuronal Activity

enthalten in: International journal of molecular sciences | 2023

von Reale, M. | Borlongan, C. | Carta, A. | +1

3

Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease

enthalten in: Journal of neurology | 2023

von Angius, F. | Mocci, I. | Ercoli, T. | +7

4

Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2

enthalten in: EMBO molecular medicine | 2023

von Indrigo, M. | Morella, I. | Orellana, D. | +22

5

Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa

enthalten in: Nutrients | 2023

von Scherma, M. | Palmas, M. | Pisanu, A. | +6

6

Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease

enthalten in: Journal of neurology | 2023

von Angius, F. | Mocci, I. | Ercoli, T. | +7

7

Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2

enthalten in: EMBO Molecular Medicine | 2023

von Indrigo, M. | Morella, I. | Orellana, D. | +22

8

The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex

enthalten in: Cells | 2022

von Palmas, M. | Etzi, M. | Pisanu, A. | +16

9

BDNF Alterations in Brain Areas and the Neurocircuitry Involved in the Antidepressant Effects of Ketamine in Animal Models, Suggest the Existence of a Primary Circuit of Depression

enthalten in: Journal of integrative neuroscience | 2022

von Carboni, E. | Carta, A.

10

Repurposing Pomalidomide as a Neuroprotective Drug : Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2022

von Palmas, M. | Ena, A. | Burgaletto, C. | +16

1
2
3
4
5
6
7
8
9
Nächster »
[9]